Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dose Response Curve: Conventional Versus Nonmonotonic01:21

Dose Response Curve: Conventional Versus Nonmonotonic

The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response relationships...
Pharmacodynamic Models: Linear Concentration–Effect Model01:15

Pharmacodynamic Models: Linear Concentration–Effect Model

The linear concentration–effect model, underpinned by the principle that pharmacological effect (E) is directly proportional to plasma drug concentration (C), emerges as a pivotal simplification of the Emax model for conditions where C is significantly less than EC50. This model portrays a linear trajectory of the concentration–effect relationship when drug levels are markedly below the EC50 threshold.Despite its inherent assumption of continuous effect augmentation with increasing drug...
Toxicokinetics: Overview01:21

Toxicokinetics: Overview

Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Pharmacodynamic Models: Logarithmic Concentration–Effect Model01:15

Pharmacodynamic Models: Logarithmic Concentration–Effect Model

The log-linear model is a pharmacological framework used to describe the relationship between drug concentration and its effect. This model is particularly relevant when the observed effects range between 20% and 80% of the drug’s maximum effect (Emax), where a near-linear relationship is observed between the log of drug concentration and the measured effect. However, the log-linear model does not predict the maximum possible effect (Emax) or the effect at zero drug concentration, limiting its...
Pharmacodynamic Models: Emax Drug–Concentration Effect Model01:18

Pharmacodynamic Models: Emax Drug–Concentration Effect Model

The Emax drug-concentration effect model is central to pharmacodynamics in drug discovery and development. This model is predicated on the receptor occupancy theory, which posits that the effect of a drug is directly related to the number of receptors occupied by the drug and the resultant complex formation.The model describes the reversible interaction between a drug (C) and a receptor (R) to form a drug-receptor complex (RC). The kinetics of this interaction are quantified by an equation that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Higher blood lipid levels after the transition to menopause in two forager-horticulturalist populations.

Evolution, medicine, and public health·2025
Same author

Deep learning analysis provides accurate COVID-19 diagnosis on chest computed tomography.

European journal of radiology·2020
Same author

Observation of a many-body dynamical phase transition with a 53-qubit quantum simulator.

Nature·2017
Same author

Preferred Hearing Aid Response Characteristics Under Acoustic and Telecoil Coupling Conditions.

American journal of audiology·2015
Same author

Trade-Offs between female food acquisition and child care among hiwi and ache foragers.

Human nature (Hawthorne, N.Y.)·2013
Same author

The influence of brightness on functional assessment by mferg: a study on scaffolds used in retinal cell transplantation in pigs.

Stem cells international·2012

Related Experiment Video

Updated: Jun 25, 2026

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
08:25

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

A model for the toxic dose under time-varying concentration.

H Kaplan1

  • 1Israel Institute for Biological Research, Ness-Ziona, Israel. khadas1@gmail.com

Journal of Hazardous Materials
|February 6, 2009
PubMed
Summary

The effective dose concept accounts for physiological recovery, reducing predicted casualties in time-varying toxic exposure scenarios. This approach resolves paradoxes in dose-load calculations for intermittent exposures.

More Related Videos

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

Published on: May 10, 2016

Related Experiment Videos

Last Updated: Jun 25, 2026

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
08:25

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

Published on: May 10, 2016

Area of Science:

  • Toxicology
  • Risk Assessment
  • Environmental Health

Background:

  • Traditional dose-load calculations rely on constant toxic exposure, common in animal studies.
  • Accident scenarios often involve time-varying toxic material concentrations, challenging existing models.
  • Additive dose-load assumptions create paradoxes with intermittent exposures.

Purpose of the Study:

  • To extend the dose-load concept for time-varying toxic exposures.
  • To introduce the effective dose concept incorporating physiological recovery.
  • To resolve paradoxes in dose-load calculations for intermittent exposure scenarios.

Main Methods:

  • Developed the effective dose concept, integrating physiological recovery.
  • Analyzed intermittent toxic concentration time series.
  • Evaluated the protective role of buildings as shelters against toxic gases.

Main Results:

  • The effective dose concept reduces predicted casualties in intermittent exposure scenarios.
  • Physiological recovery processes are crucial for accurate risk assessment.
  • Buildings significantly mitigate risks from instantaneous toxic gas releases.

Conclusions:

  • The effective dose provides a more realistic risk assessment for time-varying exposures.
  • Intermittent toxic exposures require accounting for recovery to avoid paradoxical outcomes.
  • Shelter in buildings is a critical factor in hazard evaluation for toxic releases.